Scheme 5
Scheme 6
yield for the six steps16,17 with an E:Z ratio of 2:1 (Scheme
5). The E-isomer of 34 (readily separable from the Z-isomer)
reacted with 10 and 3518 to give aza-spirocycles 36a and
36b in 57-78% yield as single diastereomers unambiguously
assigned using NOE experiment. Hydrogenation of 36a and
36b led to 37a and 37b quantitatively, thereby furnishing in
a very short sequence three contiguous stereocenters of
perhydrohistrionicotoxin.12,19-22 In comparison to known
approaches to this natural product,12,20-22 this represents a
novel approach to aza-spiroundecane ring systems with a
high level of diastereomeric control at the aza-spiro center.
Transformation of the 2-pyrone ring of 37b to the desired
simple n-amyl side chain proved to be challenging. However,
we encountered a unique if not unprecedented decarboxy-
lation protocol when 37b was treated with LAH. After a
simple quenching with ethanol followed by filtration through
Celite, the crude mixture was subjected to 60 psi of H2 in
the presence of Pd-C (Scheme 6). The product 38 was
isolated in a repeatable manner with a consistent yield in
the range of 40-60%. The compound 38 was not unambigu-
ously assigned until the subsequent acidic desilylation
followed by debenzylation of 39 using Pearlman’s catalyst
led to 2-epi-(()-perhydrohistrionicotoxin 4022 in 90% overall
yield. This completes an 11-step total synthesis of 40 in 21%
yield.
It is not clear, however, how the decarboxylation of the
2-pyrone ring had occurred. To simply balance the equation,
losing CO2 from 37b could give an amino diene intermediate
41, and addition of 2 equiv of hydrogen would then lead to
38. Although any discussions at this point are all quite
speculative, the presence of this amino diene intermediate
41 does lend support to the observed stereochemical outcome
in the hydrogenation. The subsequent hydrogenation of 41
should occur from the back face away from the TBSO (and/
or n-Bu) group, leading to 38 with an exclusive epi
stereoselection at C2.
(16) Wender, P. A.; Erhardt, J. M.; Letendre, L. J. Am. Chem. Soc. 1981,
103, 2114.
(17) Tanner, D.; Hagberg, L.; Poulsen, A. Tetrahedron 1999, 55, 1427.
(18) The N-benzyl aminopyrone 35 was prepared by treating 4-trimeth-
ylsilyloxy-6methyl-2-pyone with n-BuLi followed by quenching with EtI.
Subsequent transformation to the corresponding N-benzyl aminopyrone was
carried according to ref 14a.
We have described here a highly stereoselective and novel
approach to aza-spirocycles. An application toward synthesis
of 2-epi-perhydrohistrionicotoxin was completed with the
finding of an unprecedented decarboxylation of the 2-pyrone
ring. Efforts toward synthesis of relevant spirocyclic nitrogen
alkaloids and understanding of this decarboxylation process
are underway.
(19) For isolation, see: Daly, J. W.; Karle, I.; Myer, C. W.; Tokuyama,
T.; Waters, J. A.; Witkop, B. Proc. Natl. Acad. Sci. U.S.A. 1971, 68, 1870.
(20) For the first syntheses of (()-perhydrohistrionicotoxin, see: (a)
Coery, E. J.; Arnett, J. F.; Widiger, G. N. J. Am. Chem. Soc. 1975, 97,
430. (b) Aratani, M.; Dunkerton, L. V.; Fukuyama, T.; Kishi, Y.; Kakoi,
H.; Sugiura, S.; Inoue, S. J. Org. Chem. 1975, 40, 2009.
(21) For recent efforts in total synthesis of perhydrohistrionicotoxin or
histrionicotoxin, see: (a) Williams, G. M.; Roughley, S. D.; Davies, J. E.;
Holmes, A. B.; Adams, J. P. J. Am. Chem. Soc. 1999, 121, 4900. (b) Comins,
D. L.; Zhang, Y.-M.; Zheng, X. J. Chem. Soc., Chem. Commun. 1998, 2509.
(c) Tanner, D.; Hagberg, L. Tetrahedron 1998, 54, 7907. (d) Comins, D.
L.; Zheng, X. J. Chem. Soc., Chem. Commun. 1994, 2681. (e) Stork, G.;
Zhao, K. J. Am. Chem. Soc. 1990, 112, 5875. (f) Winkler, J. D.; Hershberger,
P. M. J. Am. Chem. Soc. 1989, 111, 4852. (g) Tanner, D.; Selle´n, M.;
Ba¨ckvall, J.-E. J. Org. Chem. 1989, 54, 3374. (h) Duhamel, P.; Kotera,
M.; Monteil, T.; Marabout, B. J. Org. Chem. 1989, 54, 4419. For the first
synthesis of (()-histrionicotoxin, see: (i) Carey, S. C.; Aratani, M.; Kishi,
Y. Tetrahedron Lett. 1985, 26, 5887.
Acknowledgment. R.P.H. thanks National Institutes of
Health (NS38049) and ACS PRF-Type-G for financial
support. Authors also thank Mr. William B. Brennessel for
providing the X-ray structural analysis.
Supporting Information Available: Experimental pro-
cedures, NMR spectral characterization data, and X-ray data
for all new compounds. This material is available free of
(22) For matching the characterization 2-epi-(()-perhydrohistrionic-
otoxin, see: Takahashi, K.; Wiktop, B.; Brossi, A.; Maleque, M. A.;
Albuquerque, E. X. HelV. Chim. Acta 1982, 6, 252.
OL020052O
2020
Org. Lett., Vol. 4, No. 12, 2002